Compositions Comprising Mg29 Nucleic Acids, Polypeptides and Associated Methods of Use

Disclosed herein are compositions and methods for treatment of muscle dysfunction (including sarcopenia) and other diseases involving skeletal musle, including age-related muscle dysfunction. In addition, the invention relates to therapeutic compositions comprising nucleotides and/or polypeptides of the invention in combination with a pharmaceutically acceptable carrier, wherein the composition facilitates the treatment of skeletal musle disorder, including those related to thr normal aging process. Moreover, the invention relates to the treatment and/or prevention of pathological conditions associated with altered intracellular Ca2+ reulgation and disrupted membrane structure that occurs when the expression levels of MG29 are reduced.

Patents:
EP 2,320,931

Inventor(s): MA JIANJIE [US]; WEISLEDER NOAH [US]

Type of Offer: Licensing



« More Biotech Patents

---